Abstracts Archive - Page 2112 of 2425 - ACR Meeting Abstracts

Abstract Number: 2103 • 2013 ACR/ARHP Annual Meeting
Relationships Between Self-Efficacy, Outcome Expectancy, and Outcomes In Older Adults With Osteoarthritis Of The Knee and Hypertension: Baseline Results
Elizabeth A. Schlenk¹, Deborah Crowley-Lisowski¹, Sarah Twerski¹, Alice Fallon¹, Alyssa Sartore¹, Susan Sereika¹, Joan Rogers², G. Kelley Fitzgerald³ and C. Kent Kwoh⁴, ¹School of Nursing, University of Pittsburgh, Pittsburgh, PA, ²School of Health and Rehabilitation Sciences, Occupational Therapy, University of Pittsburgh, Pittsburgh, PA, ³School of Health and Rehabilitation Sciences, Physical Therapy, University of Pittsburgh, Pittsburgh, PA, ⁴School of Medicine, Department of Medicine, Division of Rheumatology and Clinical Immunology, University of Pittsburgh, Pittsburgh, PA
Background/Purpose: Staying Active with Arthritis (STAR), an intervention guided by Bandura’s Self-Efficacy Theory, is being investigated in an ongoing clinical trial of an individually delivered,…
Abstract Number: 2104 • 2013 ACR/ARHP Annual Meeting
Exercise For Ankylosing Spondylitis: It′s Still Important
Janet Millner¹, John Barron², Kirsty Beinke³, Rachael Butterworth⁴, Briony Chasle⁵, Lindsay Dutton⁶, Margaret Lewington⁷, Errol Lim⁴, Tony Morley⁸, Jennie O'Reilly⁹, Kathryn Pickering¹⁰ and Jane Zochling¹, ¹Menzies Research Institute Tasmania, Hobart, Australia, ²Eastwood Physiotherapy, Adelaide, Australia, ³Adelaide West Pilates Physiotherapy, Adelaide, Australia, ⁴BJC Health, Sydney, Australia, ⁵South East Sydney Area Health Service, Sydney, Australia, ⁶Royal Perth Hospital, Perth, Australia, ⁷Hydrohealth, Brisbane, Australia, ⁸Physio Plus, Lismore, Australia, ⁹Physiotherapy, Melbourne, Australia, ¹⁰Curtin University, Perth, Australia
Background/Purpose: Previous systematic reviews [1] and international consensus [2] have agreed that exercise is beneficial in ankylosing spondylitis (AS), and this concept is widely supported…
Abstract Number: 2105 • 2013 ACR/ARHP Annual Meeting
Differences In Spinal Mobility Measures In Relation To Disease Duration and Between Subgroups With Axial Spondyloarthritis
Elisabeth.A Mogard¹, Elisabet Lindqvist², Stefan Bergman^3,4 and Ann B. I. Bremander⁴, ¹Department of Clinical Sciences, Section of Rheumatology and Skåne University Hospital, Lund University, Lund, Sweden, ²Department of Clinical Sciences Lund, Section of Rheumatology and Skåne University Hospital, Lund University, Lund, Sweden, ³Spenshult Research and Development Center, Halmstad, Sweden, ⁴Department of Clinical Sciences, Section of Rheumatology, Lund University, Lund, Sweden
Background/Purpose: Spinal mobility is a core domain for research and clinical practice in Ankylosing Spondylitis (AS) but less studied in undifferentiated SpA (USpA). Our objective…
Abstract Number: 2106 • 2013 ACR/ARHP Annual Meeting
Aquatic Exercise Training For Fibromyalgia: A Systematic Review
Julia Bidonde¹, Angela J. Busch², Sandra Webber³, Candice Schachter², Adrienne Danyliw⁴, Tom Overend⁵, Rachel Richards⁶ and Tamara Rader⁷, ¹Community Health and Epidemiology, University of Saskatchewan, Saskatoon, SK, Canada, ²School of Physical Therapy, University of Saskatchewan, Saskatoon, SK, Canada, ³School of Medical Rehabilitation, Faculty of Medicine, University of Manitoba, Winnipeg, MB, Canada, ⁴Health Quality Council, Saskatoon, SK, Canada, ⁵School of Physical Therapy, Western Universtiy, London, ON, Canada, ⁶North Shore Sports Medicine Clinic, North Vancouver, BC, Canada, ⁷University of Ottawa, Ottawa, ON, Canada
Background/Purpose: Fibromyalgia (FM) is a chronic pain condition leading to reduced physical function. Exercise training is recommended for people with FM. We examined randomized controlled…
Abstract Number: 2107 • 2013 ACR/ARHP Annual Meeting
Benefitial Effects Of a Simple Stretching Exercise Program For Patients With Ankylosing Spondylitis: A Randomized Controlled Trial
Andréa L. Gallinaro¹, Carla G.S. Saad¹, Claudia Goldenstein-Schainberg¹, Percival D sampaio-Barros¹, Julio C. B. Moraes¹, Hamilton Roschel², Ana Lucia S. Pinto¹ and Celio R. Gonçalves³, ¹Reumatologia, Faculdade de Medicina, Universidade de São Paulo, São Paulo, Brazil, ²Universidade de São Paulo, Faculdade de Educação Física e Esporte, São Paulo, Brazil, ³Rheumatology Division, Faculdade de Medicina da Universidade de São Paulo, São Paulo, Brazil
Background/Purpose: Static and dynamic stretching exercises are applied in Ankylosing Spondylitis (AS) patients to preserve and restore the axial mobility. However, there are no data…
Abstract Number: 2108 • 2013 ACR/ARHP Annual Meeting
Pre- and Postoperative Physical Therapy In Total Hip and Knee Replacement Surgery: A Multi Center Study
Wilfred FH Peter^1,2, Claire Tilbury³, Rutger Tordoir⁴, Suzan Verdegaal⁵, Ron Onstenk⁶, Menno Benard⁷, Stephan Vehmeijer⁸, Enrike van der Linden-van der Zwaag¹, Eric Vermeulen¹, Rob Nelissen¹ and Thea VlietVlieland⁹, ¹Department of Orthopaedics, Leiden University Medical Center, Leiden, Netherlands, ²Reade, center for rehabilitation and rheumatology, Amsterdam, Nicaragua, ³Departement of Orthopedics, Leiden University Medical Center, Leiden, Netherlands, ⁴Departement of orthopedics, Rijnland Hospital, Leiderdorp, Netherlands, ⁵Departement of Orthopedics, Rijnland Hospital, Leiderdorp, Netherlands, ⁶Department of Orthopedics, Het Groene Hart Hospital, Gouda, Netherlands, ⁷Departement of Orthopedics, Reinier de Graaf Hospital, Delft, Netherlands, ⁸Department of Orthopedics, Reinier de Graaf Hospital, Delft, Netherlands, ⁹Department of Orthopaedics, Leids University Medical Center, Leiden, Netherlands
Background/Purpose: Physical therapy shown to be effective after Total Hip and Knee Arthroplasty. Less evidence is available for preoperative physical therapy in Total Hip and…
Abstract Number: 2069 • 2013 ACR/ARHP Annual Meeting
Serum Interferon-α Is a Biomarker To Reflect The Disease Activity In Patients With Anti-Melanoma Differentiation-Associated Gene 5 (MDA5) Antibody-Positive Dermatomyositis
Yoshiro Horai¹, Tomohiro Koga², Keita Fujikawa³, Ayuko Takatani⁴, Ayako Nishino¹, Yoshikazu Nakashima⁵, Takahisa Suzuki⁵, Shin-ya Kawashiri¹, Naoki Iwamoto⁵, Kunihiro Ichinose⁶, Mami Tamai⁵, Hideki Nakamura⁵, Hiroaki Ida⁷, Yuji Ishimatsu⁸, Hiroshi Mukae⁹, Yasuhito Hamaguchi¹⁰, Manabu Fujimoto¹¹, Masataka Kuwana¹², Tomoki Origuchi¹³, Shigeru Kohno⁸ and Atsushi Kawakami⁵, ¹Department of Immunology and Rheumatology, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan, ²Departments of Immunology and Rheumatology, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan, ³Arthritis and Connective Tissue Disease, Isahaya Health Insurance General Hospital, Isahaya, Japan, ⁴Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan, ⁵Unit of Translational Medicine, Department of Immunology and Rheumatology, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan, ⁶Department of Immunology and Rheumatology, Unit of Translational Medicine, Department of Immunology and Rheumatology, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan, ⁷Department of Internal Medicine, Division of REspirology, Neurology and Rheumatology, Kurume University School of Medicine, Kurume, Japan, ⁸Department of Molecular Microbiology and Immunology, Nagasaki University School of Medicine, Nagasaki, Japan, Nagasaki, Japan, ⁹Department of Respiratory Medicine, University of Occupational and Environmental Health, Kitakyushu, Japan, Kitakyushu, Japan, ¹⁰Department of Dermatology, Kanazawa University Graduate School of Medical Sciences, Kanazawa, Japan, ¹¹Dermatology, Kanazawa University Graduate School of Medical Sciences, Kanazawa, Japan, ¹²Division of Rheumatology, Department of Internal Medicine, Keio University School of Medicine, Tokyo, Japan, ¹³Department of Health Sciences, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan
Background/Purpose: The pathogenesis of anti-melanoma differentiation-associated gene 5 (MDA5) antibody (Ab)-positive dermatomyositis (DM), which often complicates rapidly progressive interstitial lung disease (RPILD), is thought to…
Abstract Number: 2070 • 2013 ACR/ARHP Annual Meeting
Cytokine Profiles In Polymyositis and Dermatomyositis Complicated With Anti-Melanoma Differentiation-Associated Gene 5 Antibody-Associated Interstitial Lung Disease Or Anti-Aminoacyl tRNA Synthetase Antibody-Associated Interstitial Lung Disease
Takahisa Gono, Yasushi Kawaguchi, Hirotaka Kaneko, Yasuhiro Katsumata, Masanori Hanaoka, Sayuri Kataoka, Hidenaga Kawasumi, Kae Takagi, Hisae Ichida, Sayumi Baba, Yuko Okamoto, Yuko Ota and Hisashi Yamanaka, Institute of Rheumatology, Tokyo Women's Medical University, Tokyo, Japan
Background/Purpose: Polymyositis (PM) / dermatomyositis (DM) are often complicated with interstitial lung disease (ILD). In PM/DM, complication with ILD is associated with anti-aminoacyl-tRNA synthetase (ARS),…
Abstract Number: 2071 • 2013 ACR/ARHP Annual Meeting
Adipokines Contribute To The Inflammatory Response In Adult and Juvenile Myositis
Molly S. Hein¹, Cynthia S. Crowson², Helen Khun², Consuelo Lopez de Padilla³, Erik J. Peterson⁴, Emily Baechler⁵ and Ann M. Reed¹, ¹Rheumatology, Mayo Clinic, Rochester, MN, ²Department of Health Sciences Research, Mayo Clinic, Rochester, MN, ³Rheumatology/Immunology Research, Mayo Clinic, Rochester, MN, ⁴Medicine/Rheumatic and Autoimmune Diseases, University of Minnesota Medical School, Minneapolis, MN, ⁵Medicine, University of Minnesota, Minneapolis, MN
Background/Purpose: Recently adipokines have been implicated for their role in regulating immune and inflammatory responses in autoimmune disease. To test the hypothesis that adipokines are…
Abstract Number: 2072 • 2013 ACR/ARHP Annual Meeting
Decreased Number Of Circulating NK Cells and Dramatic Lack Of IFN-Gamma Production In Patients With Antisynthetase Syndrome
Baptiste Hervier^1,2, Yves Allenbach^3,4, Fleur Cohen-Aubart⁵, Micheline Pha⁶, Lenaig Mescam-Mancini⁷, David Saadoun⁸, Alexis Mathian^5,6, Olivier Benveniste^9,10 and Vincent Vieillard¹, ¹INSERM UMR-S 1135, UPMC, Paris, France, ²Internal Medicine & Clinical Immunology Dpt, Pitié-Salpêtrière Hospital, APHP, Paris, France, ³Internal Medicine Dpt 1, Pitié-Salpêtrière Hospital, APHP, Paris, France, ⁴INSERM UMR974, UPMC, Paris, France, ⁵Internal Medicine Dpt 2, Pitié-Salpêtrière Hospital, APHP, Paris, France, ⁶INSERM UMR-S 945, UPMC, Paris, France, ⁷Pathology Dpt, University hospital, Grenoble, France, ⁸DHU 2iB Internal Medicine Referal Center for Autoimmune diseases Pitie Hospital, Paris, France, ⁹UMR 974, Sorbonne Universités, University Pierre et Marie-Curie-Paris 6, INSERM, Paris, France, ¹⁰Internal Medecine Dpt 1, Pitié-Salpêtrière Hospital, APHP, Paris, France
Background/Purpose: Antisynthetase syndrome (ASS) is a rare autoimmune myositis associated with interstitial lung disease (ILD) and characterized by specific anti-tRNA-synthetase autoantibodies (ARS). To date, the…
Abstract Number: 2073 • 2013 ACR/ARHP Annual Meeting
Clinical and Prognostic Factors Associated With Survival In Mexican Patients With Idiopathic Inflammatory Myopathies
Angeles Shunashy Galindo-Feria¹, Jorge Rojas-Serrano² and Andrea Hinojosa-Azaola¹, ¹Immunology and Rheumatology, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico, ²Interstitial Lung Diseases Unit, Instituto Nacional de Enfermedades Respiratorias, Mexico City, Mexico
Background/Purpose: Idiopathic inflammatory myopathies (IIM) are a heterogeneous group of autoimmune diseases, with low prevalence and 5-year survival of 70-95%. Previous studies in Mexican IIM…
Abstract Number: 2074 • 2013 ACR/ARHP Annual Meeting
The Analysis Of Prognostic Factors In Patients With Inflammatory Myopathies and Amyopathic Dermatomiositis Complicated With Interstitial Lung Disease
Maasa Hama¹, Yumiko Sugiyama¹, Yohei Kirino¹, Yosuke Kunishita¹, Daiga Kishimoto¹, Reikou Kamiyama¹, Kaoru Minegishi¹, Ryusuke Yoshimi¹, Yukiko Asami¹, Atsuhisa Ueda¹, Mitsuhiro Takeno¹, Ichiro Aoki² and Yoshiaki Ishigatsubo¹, ¹Department of Internal Medicine and Clinical Immunology, Yokohama City University Graduate School of Medicine, Yokohama, Japan, ²Department of Molecular Pathology, Yokohama City University Graduate School of Medicine, Yokohama, Japan
Background/Purpose: Because interstitial lung disease (ILD) is one of the most critical manifestations and can be lethal in inflammatory myopathies (IM), especially amyopathic dermatomiositis (ADM),…
Abstract Number: 2075 • 2013 ACR/ARHP Annual Meeting
Analysis Of The Associations Between Serum Ferritin and Cytokines In Pulmonary Disease Activity With Polymyositis/Dermatomyositis
Hidenaga Kawasumi, Takahisa Gono, Yasushi Kawaguchi, Yasuhiro Katsumata, Masanori Hanaoka, Sayuri Kataoka, Kae Takagi, Hisae Ichida, Sayumi Baba, Yuko Okamoto, Yuko Ota and Hisashi Yamanaka, Institute of Rheumatology, Tokyo Women's Medical University, Tokyo, Japan
Background/Purpose: Polymyositis (PM) / dermatomyositis (DM) is occasionally complicated by interstitial lung disease (ILD), and ILD is a prognostic factor in PM/DM. We previously reported…
Abstract Number: 2076 • 2013 ACR/ARHP Annual Meeting
Oxidation Products Of Arachidonic Acid and Linoleic Acid Are Increased In High Density Lipoprotein From Patients With Dermatomyositis and Polymyositis
Christina Charles-Schoeman¹, Yuen Yin Lee¹, Ani Shahbazian¹, David Meriwether², Geraldine Navarro¹, John D. FitzGerald¹ and Srinivasa T. Reddy², ¹Medicine-Rheumatology, UCLA David Geffen School of Medicine, Los Angeles, CA, ²Medicine-Cardiology, UCLA David Geffen School of Medicine, Los Angeles, CA
Background/Purpose: Oxidation products of arachidonic acid and linoleic acid including hydroxyeicosatetraenoic acids (HETEs) and hydroxyoctadecadienoic acids (HODEs), respectively, play an important role in the…
Abstract Number: 2077 • 2013 ACR/ARHP Annual Meeting
Inflammatory Lung Disease a Potential Risk Factor For Onset Of Inflammatory Myopathies
Ingrid E. Lundberg¹, Sevim Barbasso Helmers² and Lars Alfredsson³, ¹Rheumatology Unit, Karolinska University Hospital, Solna, Karolinska Institutet, Stockholm, Sweden, ²Institute of Environmental Medicine, Unit of Cardiovascular Epidemiology, Karolinska Institutet, Stockholm, Sweden, ³Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden
Background/Purpose: Although the etiology of inflammatory myopathies is unclear, there are data indicating that myositis occurs as a result of complex interactions between genes and…

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].